Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT

Author： Ou Xueling Cai Shaohui Liu Peng Zeng Jun He Yuwen Wu Xinyao Du Jun

ISSN： 0171-5216

Source： Journal of Cancer Research and Clinical Oncology, Vol.134, Iss.5, 2008-05, pp. : 525-533

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Generation of dendritic cell–tumor cell hybrids by electrofusion for clinical vaccine application

By Trevor Katrina Cover Cathleen Ruiz Yvette Akporiaye Emmanuel Hersh Evan Landais Didier Taylor Rachel King Alan Walters Richard

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 8, 2004-08 ,pp. : 705-714

Springer Publishing Company

Access to resources Recommend Favorite

Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients

International Journal of Oncology, Vol. 43, Iss. 1, 2013-01 ,pp. : 280-288

Spandidos Publications

Access to resources Recommend Favorite

Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression

By Wobser Marion Voigt Heike Houben Roland Eggert Andreas Freiwald Matthias Kaemmerer Ulrike Kaempgen Eckhart Schrama David Becker Juergen

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 7, 2007-07 ,pp. : 1017-1024

Springer Publishing Company

Access to resources Recommend Favorite

Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation

Oncology Reports, Vol. 28, Iss. 5, 2012-01 ,pp. : 1574-1578

Spandidos Publications

Access to resources Recommend Favorite

Immunological suppression of head and neck carcinoma by dendritic cell tumor fusion vaccine

Oncology Letters, Vol. 6, Iss. 6, 2013-01 ,pp. : 1799-1803

Spandidos Publications

Access to resources Recommend Favorite